Research programme: sphingosine-1-phosphate - York Pharma
Alternative Names: S1P; YP 005Latest Information Update: 24 Oct 2021
At a glance
- Originator Freie Universitat Berlin; York Pharma
- Class Amino alcohols; Antipsoriatics; Lysophospholipids
- Mechanism of Action Lysosphingolipid receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Skin disorders
Most Recent Events
- 17 Jan 2008 Sphingosine-1-phosphate is still in preclinical trials for Skin disorders in Germany
- 08 May 2006 Preclinical trials in Skin disorders in Germany (unspecified route)